Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial.

Journal:

Journal of Clinical Oncology

Published:

2025-12-13

DOI:

10.1200/jco-25-01868

Affiliations:

40

Authors:

47

Go to article

Institutions	Authors	Share
Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, United Kingdom (UK)	8.500000	0.18
The Royal Marsden Hospital - London, The Royal Marsden NHS Foundation Trust, United Kingdom (UK)	4.000000	0.09
Vall d'Hebron University Hospital (HUVH), ICS, Spain	2.000000	0.04
NIHR Birmingham Biomedical Research Centre, United Kingdom (UK)	1.500000	0.03
Erasmus MC-Sophia, Netherlands	1.000000	0.02
Centre Oscar Lambret, France	1.000000	0.02
Great Ormond Street Hospital for Children (GOSH), United Kingdom (UK)	1.000000	0.02
Bristol Royal Hospital for Children (BRHC), UHBW NHS, United Kingdom (UK)	1.000000	0.02
IRCCS Bambino Gesù Children's Hospital, Italy	1.000000	0.02
Sheffield Children’s Hospital, Sheffield Children's NHS Foundation Trust, United Kingdom (UK)	1.000000	0.02
Our Lady's Children’s Hospital, Ireland	1.000000	0.02
Hospital Infantil Universitario Niño Jesús, Spain	1.000000	0.02
Brabois Hospital, CHRU Nancy, France	1.000000	0.02
Princess Maxima Centre for Pediatric Oncology (PMC), Netherlands	1.000000	0.02
University Hospital Nantes (CHU de Nantes), France	1.000000	0.02
Hôpital de Hautepierre, Université de Strasbourg, France	1.000000	0.02
Curie Institute, France	1.000000	0.02
University Hospital Saint-Luc, Belgium	1.000000	0.02
Copenhagen University Hospital (CUH), Denmark	1.000000	0.02
Leeds General Infirmary, LTHT, United Kingdom (UK)	1.000000	0.02
Children's Hospital, CHU-Toulouse, France	1.000000	0.02
University Children's Hospital of Zurich, Switzerland	1.000000	0.02
University of Southampton (Soton), United Kingdom (UK)	1.000000	0.02
Health Research Institute (IIS La Fe), Spain	1.000000	0.02
Al Jalila Children's Hospital, United Arab Emirates	1.000000	0.02
Institute Gustave-Roussy (IGR), France	1.000000	0.02
Ghent University Hospital, Belgium	1.000000	0.02
Alder Hey Children’s Hospital, Alder Hey Children's NHS Foundation Trust, United Kingdom (UK)	1.000000	0.02
Centre Léon Bérard (CLB), France	1.000000	0.02
Royal Belfast Hospital for Sick Children, NHSCT, United Kingdom (UK)	1.000000	0.02
Royal Manchester Children's Hospital, MFT, United Kingdom (UK)	1.000000	0.02
Hospital de Cruces, Spain	0.500000	0.01
Biobizkaia Health Research Institute (IIS Biobizkaia), Spain	0.500000	0.01
Birmingham Women's Hospital, Birmingham Women's and Children's NHS Foundation Trust, United Kingdom (UK)	0.500000	0.01
Birmingham Children's Hospital, Birmingham Women's and Children's NHS Foundation Trust, United Kingdom (UK)	0.500000	0.01
St. Anna Children's Hospital, Austria	0.500000	0.01
Medical University of Vienna (MUW), Austria	0.500000	0.01
Royal Victoria Infirmary (RVI), NUTH, United Kingdom (UK)	0.500000	0.01
Newcastle University, United Kingdom (UK)	0.500000	0.01

Interested in Oncology and Carcinogenesis?